Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3QX9

Crystal structure of MID domain from hAGO2 in complex with ATP

3QX9 の概要
エントリーDOI10.2210/pdb3qx9/pdb
関連するPDBエントリー3LUC 3QX8
分子名称Protein argonaute-2, ADENOSINE-5'-TRIPHOSPHATE (3 entities in total)
機能のキーワードrossmann-like fold, rna binding protein
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm, P-body: Q9UKV8
タンパク質・核酸の鎖数3
化学式量合計47499.41
構造登録者
Frank, F.,Fabian, M.R.,Stepinski, J.,Jemielity, J.,Darzynkiewicz, E.,Sonenberg, N.,Nagar, B. (登録日: 2011-03-01, 公開日: 2011-04-20, 最終更新日: 2024-02-21)
主引用文献Frank, F.,Fabian, M.R.,Stepinski, J.,Jemielity, J.,Darzynkiewicz, E.,Sonenberg, N.,Nagar, B.
Structural analysis of 5'-mRNA-cap interactions with the human AGO2 MID domain.
Embo Rep., 12:415-420, 2011
Cited by
PubMed Abstract: In RNA silencing, microRNA (miRNA)-mediated translational repression occurs through mechanisms that do not invoke messenger-RNA (mRNA) target cleavage by Argonaute proteins. The nature of these mechanisms is unclear, but several recent studies have proposed that a direct interaction between the mRNA-cap and the middle (MID) domain of Argonautes is involved. Here, we present crystallographic and NMR data demonstrating that cap analogues do not bind significantly to the isolated MID domain of human Argonaute 2 (hAGO2) and are found in the miRNA 5'-nucleotide binding site in an implausible binding mode. Additionally, in vitro pull-down experiments with full-length hAGO2 indicate that the interaction with cap analogues is nonspecific.
PubMed: 21475248
DOI: 10.1038/embor.2011.48
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 3qx9
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon